Morgan Stanley thinks this little-known autoimmune biotech stock can surge more than 40%
[ad_1]
Kyverna began trading on the Nasdaq on Feb. 8, when it jumped 56% to reach a market cap of $1.4 billion.
[ad_2]
Source link
- Airbnb has a new label to denote its top (and worst) listings | TechCrunch
- Meat becomes unaffordable for millions in Turkey – Turkish Minute
